Dearman, the clean cold technology company, has today announced that it has recruited a new Vice President for European Sales.
Jan de Waard, who will be based out of Brussels, will oversee Dearman’s sales operations and customer relationships across Europe, where the company expects to grow significantly. Jan comes with 33 years of Europe-wide sales experience and joins from Czech software firm Comprimato.
His previous company, Prague-based computer science firm Cognitive Security, was acquired by Cisco. Before that, Jan worked for mobile software companies Ripcode Inc and 24access Solutions.
Having developed a zero-emission transport refrigeration unit, which is set to begin commercial deployment in Europe in the months ahead, Jan will lead Dearman’s customer engagement in target markets including France, Germany and the Benelux countries.
Jan’s appointment comes at a time of significant growth for Dearman, following the company’s major site expansion earlier this year and significant progress in the development of its cutting edge clean cold and power technologies.
Commenting, Jan de Waard, Vice President of European Sales at Dearman said:
“I am delighted to have joined Dearman, who are pioneering ground-breaking liquid nitrogen technology. The company has created a unique, zero-emission transport refrigeration unit which I know will have strong interest across Europe. As countries and companies alike look to improve local air quality, Dearman clearly have an innovative product to meet many of their needs and I look forward to leading the company’s sales around the continent.”
Deputy Chief Executive of Dearman, Michael Ayres added:
“Jan comes with over 30 years of senior level experience and his track record. He is an excellent appointment for Dearman and I am confident that he will help to drive substantial growth across the region. Dearman’s zero-emission transport refrigeration unit is ready for commercial deployment and we’re delighted to have Jan leading our engagement with European customers, for our current and future products.”
